News
At the point of writing, we’ve got only 2 full days to enjoy Unity’s ‘Buy 1 Get 1’ deals. We’re looking at 1+1 multivitamins, dietary supplements, detox enzyme drinks, and more! 🤩 Their promotion ...
The FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, ...
LENZ Therapeutics' VIZZ earns FDA approval as the first aceclidine-based eye drop to treat presbyopia, with U.S. launch expected in Q4 2025.
Aceclidine is a cholinergic muscarinic agonist that causes contraction of the iris sphincter muscle, thereby creating a pinhole effect that extends focus depth to improve vision in presbyopia.
The FDA has approved VIZZ, a once-daily, preservative-free eye drop that improves near vision in adults with presbyopia for up to 10 hours.
Small doses of the involuntary nervous system blocker, atropine, may offer a non-invasive treatment for symptomatic vitreous ...
The FDA approved Vizz for the treatment of presbyopia in adults, according to a press release from Lenz ...
The starting point for assessing NCD risk is its credit rating. All NCD issuers are rated by Sebi-accredited rating agencies, such as CRISIL, ICRA, and CARE. These ratings range from AAA (highest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results